← Back to Bills
HRES 1521118th CongressFailed / ExpiredHouse

Expressing support for the designation of September 30, 2024, as "Rare Cancer Day" to highlight the challenges patients with rare cancers face and to raise awareness and support efforts to improve early diagnosis and treatment.

Policy Area: Health
View on Congress.gov
Origin Chamber
House
Last Updated
Dec 5, 2025
Latest Action Date
Sep 27, 2024

Latest Action

Referred to the House Committee on Energy and Commerce.

Official Summary

Official summary has not been imported yet.

GovScope Watchdog™

AI Government Intelligence™
Executive Summary

House Resolution 1521 from the 118th Congress expresses support for designating September 30, 2024, as "Rare Cancer Day." The resolution aims to highlight the challenges faced by patients with rare cancers and to raise awareness and support efforts to improve early diagnosis and treatment. The bill was referred to the House Committee on Energy and Commerce but ultimately failed or expired without further action. No detailed legislative text or summary is available beyond the title and referral information.

Bottom Line

H.Res. 1521 sought to recognize Rare Cancer Day to promote awareness and support for rare cancer patients but did not advance beyond committee referral and expired.

Policy Risk Level
🟢 Low
Neutral Risk Assessment
Key Points
  • The resolution designates September 30, 2024, as Rare Cancer Day.
  • It focuses on raising awareness about the challenges faced by patients with rare cancers.
  • The bill supports efforts to improve early diagnosis and treatment of rare cancers.
  • The resolution was referred to the House Committee on Energy and Commerce.
  • The bill status is listed as Failed / Expired, indicating no further legislative progress.
Who Benefits?

['Patients with rare cancers', 'Healthcare providers and researchers focused on rare cancers', 'Advocacy organizations promoting cancer awareness', 'Public health entities involved in cancer diagnosis and treatment']

Potential Concerns

['The resolution is non-binding and does not allocate funding or mandate actions, limiting direct impact.', 'Lack of detailed legislative text or implementation mechanisms may reduce effectiveness in achieving stated goals.', 'No oversight or enforcement provisions are included.', 'As a resolution, it does not create legal obligations or policy changes.']

Political Context

The resolution was introduced in the House during the 118th Congress and referred to the House Committee on Energy and Commerce. It reflects a common legislative practice of designating awareness days to highlight health issues. The bill did not advance beyond committee referral and expired, indicating limited legislative momentum or prioritization.

Hidden Impact Review

Hidden impact flags detected: 1

GovScope reviewed 1 policy-risk categories. Hover for a quick definition. Click detected flags for bill-specific details.

1 Detected
Detected Flags
Indirect Effects

['Increased public and professional awareness of rare cancers could lead to more research interest and funding in the future.', 'Recognition of Rare Cancer Day may encourage advocacy groups to organize events and campaigns.', 'Healthcare providers might increase focus on early diagnosis efforts around the designated day.']

GovScope Watchdog Notes

The absence of a full bill text and official summary limits detailed analysis. The resolution's non-binding nature means it does not impose new requirements or funding, which reduces oversight complexity but also limits measurable impact. Tracking such resolutions is important to understand symbolic legislative actions and their role in public health awareness.

Passage Likelihood: LowConfidence: 85%Model: gpt-4.1-mini

GovScope Intelligence Roadmap

Future bill intelligence will connect sponsors, committee referrals, related votes, campaign finance, disclosures, and stock trades into one legislative intelligence view.

Enterprise Ready